⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia

IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia

Unclaimed

AEO Score: 4/10

Monitoring for AI engine activity

In the Engagemii AEO index

idhifa.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia just got measured.

4/10 means IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia

Learn more about IDHIFA® (enasidenib) for patients with relapsed/refractory acute myeloid leukemia (AML) with an IDH2 mutation. See safety info and BOXED WARNING on differentiation syndrome.

Key Topics

IDHIFA® is the first and only treatment
IDHIFA® is the first and only treatment

Details

Industry: Healthcare

idhifa.com

AI Visibility Breakdown

2

Structured Data

5

Content Structure

5

Entity Clarity

5

E-E-A-T Signals

6

Technical AEO

2

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia.

Source & Attribution

Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/idhifa

Cite this score: Engagemii (2026). "AEO Score for IDHIFA®: For Relapsed / Refractory Acute Myeloid Leukemia." Retrieved from https://engagemii.com/aeo/brands/idhifa

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform